SV1999000069A - Angiopoyetina relacionada con secuencia del gen 3 en la cicatrizacion de la cara ref. x-12261 - Google Patents

Angiopoyetina relacionada con secuencia del gen 3 en la cicatrizacion de la cara ref. x-12261

Info

Publication number
SV1999000069A
SV1999000069A SV1999000069A SV1999000069A SV1999000069A SV 1999000069 A SV1999000069 A SV 1999000069A SV 1999000069 A SV1999000069 A SV 1999000069A SV 1999000069 A SV1999000069 A SV 1999000069A SV 1999000069 A SV1999000069 A SV 1999000069A
Authority
SV
El Salvador
Prior art keywords
angiopoyetin
gen
ref
sequence
scarface
Prior art date
Application number
SV1999000069A
Other languages
English (en)
Inventor
Josef Georg Heuer
Rebecca Ann Leonard
Stanley Gene Burgett
Paul Robert Rosteck
Patanjali Raghavacharya Sankhavaram
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SV1999000069A publication Critical patent/SV1999000069A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE ACIDO NUCLEICO, DE SCARFACE 3, SUS PROTEINAS Y FRAGMENTOS AISLADOS, ESTANDO DICHAS PROTEINAS SCARFACE 3 RELACIONADAS CON LA FAMILIA DE LA ANGIOPOYETINA. TAMBIEN SE PROPORCIONAN VECTORES Y CELULAS HUESPED HETEROLOGAS TRANSFORMADAS PARA EXPRESAR SURFACE 3, PROCEDIMIENTOS PARA LA IDENTIFICACION DE COMPUESTOS QUE SE UNEN A, Y/O MODULAN LA ACTIVIDAD DE, DICHAS PROTEINAS SURFACE 3, ADEMAS DE PROCEDIMIENTOS PARA TRATAR CANCER Y LA MIELOSUPRESION, Y COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN SCARFACE 3 O SUS ANALOGOS.
SV1999000069A 1998-06-02 1999-05-28 Angiopoyetina relacionada con secuencia del gen 3 en la cicatrizacion de la cara ref. x-12261 SV1999000069A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8771698P 1998-06-02 1998-06-02
US11062098P 1998-12-02 1998-12-02
US12906599P 1999-04-13 1999-04-13
US13038199P 1999-04-21 1999-04-21

Publications (1)

Publication Number Publication Date
SV1999000069A true SV1999000069A (es) 2000-04-11

Family

ID=27492162

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1999000069A SV1999000069A (es) 1998-06-02 1999-05-28 Angiopoyetina relacionada con secuencia del gen 3 en la cicatrizacion de la cara ref. x-12261

Country Status (7)

Country Link
EP (1) EP0962466A1 (es)
AR (1) AR019851A1 (es)
AU (1) AU4227799A (es)
CO (1) CO5060478A1 (es)
PE (1) PE20000539A1 (es)
SV (1) SV1999000069A (es)
WO (1) WO1999062956A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030831A (en) * 1997-09-19 2000-02-29 Genetech, Inc. Tie ligand homologues
MXPA01006330A (es) * 1998-12-22 2002-07-02 Genentech Inc Metodos y composiciones para inhibir el crecimiento de celulas neoplasticas.
KR20010104373A (ko) * 1999-03-08 2001-11-24 제넨테크, 인크. 혈관신생 및 심혈관형성의 촉진 또는 억제 방법
DE60035693T2 (de) * 1999-07-20 2008-05-15 Genentech, Inc., South San Francisco Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
CZ20021853A3 (cs) * 1999-12-09 2002-11-13 Sankyo Company, Limited Způsob testování účinku látky, polynukleotid, DNA, protilátka, souprava pro testování, pouľití polynukleotidu, pouľití polypeptidu, pouľití protilátky, RNA a terapeutické činidlo

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU715621B2 (en) * 1995-04-06 2000-02-03 Regeneron Pharmaceuticals, Inc. TIE-2 ligands, methods of making and uses thereof
US6057435A (en) * 1997-09-19 2000-05-02 Genentech, Inc. Tie ligand homologues
US6030831A (en) * 1997-09-19 2000-02-29 Genetech, Inc. Tie ligand homologues

Also Published As

Publication number Publication date
WO1999062956A1 (en) 1999-12-09
AR019851A1 (es) 2002-03-20
CO5060478A1 (es) 2001-07-30
AU4227799A (en) 1999-12-20
EP0962466A1 (en) 1999-12-08
PE20000539A1 (es) 2000-07-05

Similar Documents

Publication Publication Date Title
ES2191011T3 (es) Acido nucleico, vector de expresion y composiciones para la identificacion y sintesis de sialiltransferasas recombinantes.
AR053063A2 (es) Proteina sustancialmente purificada y composicion farmaceutica que la comprende
MX6339E (es) Metodo para elaborar dentro de un huesped bacteriano y excretar a traves de la membrana de la celula huesped,una proteina o un polipeptido seleccionados
AR006250A1 (es) Compuestos y metodos para la inmunoterapia e inmunodiagnostico del cancer prostatico
BR0009505A (pt) Compostos e processos para terapia e diagnóstico de câncer de pulmão
DK1103564T3 (da) Cancerantigener baseret på tumorsuppressorgen WT1-produkt
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
BR9407956A (pt) Composiçao farmacêutica vetor de express o de adenovirus recombinante e kit par reduzir a proliferaçao de células tumorais
PT100515A (pt) Moleculas de acido nucleico, precursores de antigenios de rejeicao de tumores, antigenios da rejeicao de tumores e suas utilizacoes
DE69434781D1 (de) Defektive rekombinante adenoviren zur tumor-gentherapie
ES2053560T3 (es) Productos mejorados para el cuidado personal de la piel que continen polimeros tipo cloruro de dimetil dialil amonio/acido acrilico.
DK0845032T3 (da) Isolerede nucleinsyremolekyler, peptider, der danner komplekser med MHC-molekyler HLA-A2, samt anvendelser
PT88230A (pt) Processo para o isolamento de proteinas basicas a partir de proteinas que as contem
DK215287D0 (da) Dna-sekvenser, der koder for et protein med angiogen virkning, vektorer, vaertsceller og fremgangsmaader til udtrykkelse af proteinet, samt laegemidler indeholdende dette
ATE474926T1 (de) Verwendung von clya hemolysin fur ausscheidung von fusionprotein
BR112022012327A2 (pt) Anticorpos ou fragmentos dos mesmos, ácido nucleico, vetor e célula hospedeira
SV1999000069A (es) Angiopoyetina relacionada con secuencia del gen 3 en la cicatrizacion de la cara ref. x-12261
DK611386A (da) Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden
ATE350472T1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
ES2123269T3 (es) Receptores del factor 2 de liberacion de corticotropina.
DE3674764D1 (de) Transkutaner nagel zur fixierung von knochenfragmenten oder -teilen.
NO20000575L (no) Rekombinant ekspresjon av insulin C-peptid
AR009600A1 (es) Secuencia de acido nucleico y aminoacidos relacionados con helicobacter pylori y composiciones de vacuna de la misma.
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
ES2090357T3 (es) Una proteina de union a colageno asi como su preparacion.